Cargando…
Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center
Background Clopidogrel has become essential in managing coronary artery disease and other atherothrombotic diseases. It is an inactive prodrug that needs biotransformation in the liver by various cytochrome P (CYP) 450 isoenzymes for its active metabolite formation. However, 4-30% of patients on clo...
Autores principales: | Kambhampati, Nikhil Teja, Ahamed, Hisham, K.K, Velayudhan, David, Sachin, Hakeem, Sai chandra, Pillai, Gopalakrishna, Kartha, Niveditha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998108/ https://www.ncbi.nlm.nih.gov/pubmed/36913219 http://dx.doi.org/10.7759/cureus.34737 |
Ejemplares similares
-
The Association Between Microalbuminuria and QTc Prolongation in Patients With Type 2 Diabetes Mellitus: A Single-Centre Study From South India
por: Dominic, Solomon K, et al.
Publicado: (2023) -
Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus: A Single-Centre Observational Study From a Tertiary Care Hospital in South India
por: CM, Wazeem, et al.
Publicado: (2023) -
Implications of Pharmacogenetic Testing for Clopidogrel Therapy in a Tertiary Healthcare Hospital in North India
por: Amarapalli, Jayachandra, et al.
Publicado: (2023) -
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis
por: Chenna, Venkata Sai Harshabhargav, et al.
Publicado: (2023) -
An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
por: Iskandar, Nicholas P, et al.
Publicado: (2022)